Application of temperature sensitive yeast models with definite target in the screening of potential human Pin1 inhibitors

This study is to explore new lead compounds by inhibition of Pin1 for anticancer therapy using temperature sensitive mutants.As Pin1 is conserved from yeast to human, we established a high-throughput screening method for Pin1 inhibitors, which employed yeast assay.This method led to the identification of one potent hits, 8-11.In vitro, 8-11 inhibited purified Pin1 enzyme activity with IC₅₀ of (10.40 ± 1.68) μmol·L^-1, induced G₁ phase arrest and apoptosis, showed inhibitory effects on a series of cancer cell proliferation, reduced Cyclin D1 expression, was defined as reciprocally matched for protein-ligand complex in virtual docking analysis and reduced cell migration ability.In vivo, we could observe reduction of tumor volume after treatment with 8-11 in xenograft mice compared with vehicle DMSO treatment.Altogether, these results provide for the first time the involvement of 8-11 in the anticancer activity against Pin1.